CIK 0001818382 · Non-accelerated filer<br>Smaller reporting company
Humacyte, Inc.
Sign in to watch- Ticker
- HUMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851763759
- Phone
- 919-313-9633
- Business address
- 2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, NC, 27713
- Former names
- Alpha Healthcare Acquisition Corp.
- 4 Open-market buy Director bought 2,050 shares at $7.37 ($15,109)
- 4 Open-market sale Chief Operating Officer sold 191,511 shares at an average $8.15 ($1,561,605)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market buy Director bought 8,005 shares at an average $6.25 ($50,030)
- 4 Option exercise Director acquired 600 shares (option exercise)
- 4 Option exercise Director acquired 600 shares (option exercise)
- 4 Open-market buy Director bought 100,000 shares at an average $6.68 ($667,500)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- SC 13D/A Stake Beneficial Ownership Report
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Material agreement · Regulation FD disclosure
Page 11 of 26 · 506 filings